Starling Oncology, Inc. (STLN)

NASDAQ: STLN · Real-Time Price · USD

6.18

-0.23 (-3.59%)

Aug 10, 2026, 11:35 AM EDT - Market open

Starling Oncology Earnings Call Transcripts

Fiscal Year 2026

Earnings Call: Q2 2026
Q2 2026 saw record revenue growth of 34.6% year-over-year, positive adjusted EBITDA, and a successful refinancing that improved liquidity. New capitation contracts in Nevada, Oregon, and California expanded membership, while guidance for 2026 was raised across revenue, gross profit, and EBITDA.

Read full transcript →

Earnings release
Quarterly report